EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Difference between kidney function by cystatin C versus creatinine and association with muscle mass and frailty

Julia H Yuan, Dena E Rifkin, Charles Ginsberg, Peggy M Cawthon, Deborah M Kado, Scott R Bauer, Kristine E Ensrud iD, Andrew R Hoffman, O Alison Potok

Journal of the American Geriatrics Society · 2024-10 · 72 (10) · 3163-3170

DOI: 10.1111/jgs.19014 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 31.05.2024. Verfasst von Julia H Yuan und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of California San Diego, San Diego, California, USA. Hauptthemen laut MEDLINE: Cystatin C, Glomerular Filtration Rate, Frailty, Creatinine. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NIA NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A higher difference in estimated glomerular filtration rate by cystatin C versus creatinine (eGFRDiff = eGFRCys – eGFRCreat) is associated with decreased frailty risk. Since eGFRCreat is influenced by muscle more than eGFRCys, muscle mass may explain this association. Previous work could not account for this when considering regional muscle measures by imaging. Deuterated creatine (D 3 Cr) dilution measures whole body muscle mass (kilograms). We aimed to determine whether eGFRDiff is associated with D 3 Cr muscle mass and whether muscle mass explains the association between eGFRDiff and frailty.

Methods

Cross‐sectional analysis within the multicenter MrOS Study at Year 14 (visit 4). 490 men of the original cohort of 5994 MrOS participants (aged ≥65 at enrollment) were included. Exposure was eGFRDiff (= eGFRCys – eGFRCreat), calculated using CKD‐EPI equations 2012/2021. Primary outcome was D 3 Cr muscle mass. Secondary outcome was phenotypic pre‐frailty (one or two criteria) and frailty (≥three criteria) including the following: weight loss, weakness, slow gait, physical activity, poor energy. The association of eGFRDiff with D 3 Cr muscle mass was examined by linear regression, that with prefrailty / frailty by multinomial logistic regression.

Results

Mean ± SD age was 84 ± 4 years, eGFRCreat 68 ± 16, eGFRCys 52 ± 16, eGFRDiff −15 ± 12 mL/min/1.73 m 2 and D 3 Cr muscle mass 24 ± 4 kg. For each SD increment in eGFRDiff, D3Cr muscle mass was 1.4 kg higher on average, p < 0.0001 (fully adjusted). Higher eGFRDiff was associated with lower odds of frailty (OR = 0.63 95% CI [0.45;0.89]), but this was partially attenuated and insignificant after additionally adjusting for D 3 Cr muscle mass (OR = 0.85 95% CI [0.58; 1.24]).

Conclusions

Higher eGFRDiff is associated with lower odds of frailty among late‐life men. D 3 Cr muscle mass accounts for some of this association. This suggests that non‐GFR determinants of creatinine and cystatin C, such as muscle mass, play a role in explaining the association of eGFRDiff with frailty. Future studies are needed to confirm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystatin CGlomerular Filtration RateFrailtyCreatinineHumansMaleAgedCross-Sectional StudiesMuscle, SkeletalAged, 80 and overFemaleBiomarkersSarcopenia

Stichwörter der Autor:innen

cystatin CeGFRfrailtykidney functionmuscle massolder adults

Substanzen

Cystatin CCreatinineBiomarkers

Autor:innen und Institutionen

  • University of California San Diego, San Diego, California, USA.
  • Veterans Affairs San Diego Healthcare System, San Diego, California, USA.
  • University of California San Francisco, San Francisco, California, USA.
  • United States and Research Institute, California Pacific Medical Center, San Francisco, California, USA.
  • Geriatric Research Education and Clinical Center (GRECC), Veterans Healthcare Administration, Palo Alto, California, USA.
  • Stanford University, Stanford, California, USA.

ORCID-Profile: Kristine E Ensrud

Förderung

  • NIDDK NIH HHS
  • NIA NIH HHS
  • NCATS NIH HHS
  • NIAMS NIH HHS
  • National Institute on Aging
  • National Center for Advancing Translational Sciences
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Yuan, J. H., Rifkin, D. E., Ginsberg, C., Cawthon, P. M., Kado, D. M., Bauer, S. R., Ensrud, K. E., Hoffman, A. R., & Potok, O. A. (2024). Difference between kidney function by cystatin C versus creatinine and association with muscle mass and frailty. Journal of the American Geriatrics Society, 72(10), 3163-3170. https://doi.org/10.1111/jgs.19014

Vancouver

Yuan JH, Rifkin DE, Ginsberg C, Cawthon PM, Kado DM, Bauer SR, et al. Difference between kidney function by cystatin C versus creatinine and association with muscle mass and frailty. Journal of the American Geriatrics Society. 2024;72(10):3163-3170. doi:10.1111/jgs.19014

BibTeX
@article{Yuan2024,
  author = {Yuan, Julia H and Rifkin, Dena E and Ginsberg, Charles and Cawthon, Peggy M and Kado, Deborah M and Bauer, Scott R and Ensrud, Kristine E and Hoffman, Andrew R and Potok, O Alison},
  title = {Difference between kidney function by cystatin C versus creatinine and association with muscle mass and frailty},
  journal = {Journal of the American Geriatrics Society},
  year = {2024},
  volume = {72},
  number = {10},
  pages = {3163--3170},
  doi = {10.1111/jgs.19014}
}
Kostenlos starten →